Get the Stockscreener App
10.12
0.10%
0.0101
Drugs Made In America Acquisition Ii Corp stock is traded at $10.12, with a volume of 1,907.
It is up +0.10% in the last 24 hours and up +0.20% over the past month.
Drugs Made In America Acquisition II Corp is a blank check Company.
See More
Previous Close:
$10.11
Open:
$10.12
24h Volume:
1,907
Relative Volume:
0.01
Market Cap:
$644.65M
Revenue:
-
Net Income/Loss:
$8.58M
P/E Ratio:
75.52
EPS:
0.134
Net Cash Flow:
$-1.11M
1W Performance:
+0.10%
1M Performance:
+0.20%
6M Performance:
+1.30%
1Y Performance:
+0.00%
1-Day Range:
$10.12
$10.12
1-Week Range:
$10.11
$10.12
52-Week Range:
$9.87
$10.20
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Name
Drugs Made In America Acquisition Ii Corp
Sector
Industry
Phone
954-870-3104
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, CCXI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.12 | 643.69M | 0 | 8.58M | -1.11M | 0.134 |
LION
Lionsgate Studios Corp
|
12.36 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.58 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
27.14 | 984.55M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
16.10 | 764.20M | 0 | 0 | 0 | 0.0647 |
Drugs Made In America Acquisition Ii Corp Stock (DMII) Latest News
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.100|Chg%:-0.005 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Income Statement - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
QETA|Quetta Acquisition Corp|Price:11.430| - TradingKey
BLUW|Blue Water Acquisition Corp III|Price:10.340|Chg%:+0.010 - TradingKey
DRDB|Roman DBDR Acquisition Corp II|Price:10.585|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
CAPN|Cayson Acquisition Corp|Price:11.100|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey
RIBB|RIBB|Price:10.810| - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700| - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
PLMK|Plum Acquisition Corp. IV|Price:10.610| - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.681|Chg%:-0.009 - TradingKey
IBAC|IB Acquisition Corp|Price:10.730|Chg%:-0.060 - TradingKey
JENA|Jena Acquisition Corp II|Price:10.500|Chg%:+0.090 - TradingKey
WTG|Wintergreen Acquisition Corp|Price:10.475|Chg%:+0.005 - TradingKey
MYX|Maywood Acquisition 2 Ord Shs Class A|Price:9.925|Chg%:-0.005 - TradingKey
GSHR|Gesher Acquisition II Corp|Price:10.470|Chg%:-0.030 - TradingKey
Eli Lilly and Company - Encyclopedia Britannica
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) - PR Newswire
Drugs Made In America amends merger agreement terms - TipRanks
Drugs Made In America Acquisition Revises PAGC Merger; Sets $30M Target Cash and Founder Share Forfeiture - TradingView
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Encyclopedia Britannica
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Layoff Tracker: EMD Serono may trim R&D workforce by up to 70 - BioSpace
Drugs Made In America Acquisition Corp. Rights (DMAAR) Hold Steady at $0.10 Amid Low ActivityRetail Sentiment - dars.gov.et
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1%Here's What Happened - MarketBeat
Price to sales forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Price to earnings forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Drugs Made In America Acquisition Ii Corp Stock (DMII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):